Nordic Society for Clinical Chemistry 2012

Nordic Society for Clinical Chemistry 2012

Organized by Nordic Society for Clinical Chemistry (NCC) and the Icelandic Society for Clinical Chemistry and Laboratory Medicine, the NCC congress covers the forefront of science as well as current developments in the practice of Clinical Chemistry and Laboratory Medicine. The congress gathers clinicians and laboratory professionals from all of the Nordic countries.

BioPorto will be promoting The NGAL Test™- a turbidimetric assay for determination of NGAL in human urine or plasma- which can be applied to a wide range of automated clinical chemistry analyzers.

What is NGAL?
NGAL is a novel biomarker for diagnosing acute kidney injury (AKI). NGAL provides a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI). To learn more about ngal please visit: www.ngal.com

Product Manager, Elaine Lundberg (eal@bioporto.com) will be representing BioPorto Diagnostics.

To learn more about the NCC congress please go to:  http://www.nfkk2012.is/